BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO AND Prognosis
34 results:

  • 1. A Transformer-Based microvascular invasion classifier enhances prognostic stratification in HCC following radiofrequency ablation.
    Wang W; Wang Y; Song D; Zhou Y; Luo R; Ying S; Yang L; Sun W; Cai J; Wang X; Bao Z; Zheng J; Zeng M; Gao Q; Wang X; Zhou J; Wang M; Shao G; Rao SX; Zhu K
    Liver Int; 2024 Apr; 44(4):894-906. PubMed ID: 38263714
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognoses of Patients Treated With Surgical Therapy Versus Continuation of Local-Plus-Systemic Therapy Following Successful Down-Staging of Intermediate-Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study.
    Liu J; Zhu X; Pan Y; Zhong J; Jin R; Zheng X; Zhang W; Hu K; Ma J; Shi X; Liu H; Yang X; Xu D; Ma C; Chen J; Wang D; Wang X; Li Z; Zhao L; Zhang L; Li T; Liu F; Tan G; Xing B; Zhao H; Zeng Y; Zhang S; Zhang L; Zhou L; Song T; Yang W; Liang X; Xiang B; Xu L; Sun H; Wang K
    Oncologist; 2024 Apr; 29(4):e487-e497. PubMed ID: 37874924
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prediction of outcomes in patients with metabolic dysfunction-associated steatotic liver disease based on initial measurements and subsequent changes in magnetic resonance elastography.
    Kobayashi T; Iwaki M; Nogami A; Kawamura N; Honda Y; Ogawa Y; Imajo K; Yoneda M; Saito S; Nakajima A
    J Gastroenterol; 2024 Jan; 59(1):56-65. PubMed ID: 37845417
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genetic and epigenetic prognosticators of neuroendocrine tumours of the GI tract, liver, biliary tract and pancreas: A systematic review and meta-analysis.
    Mestre-Alagarda C; Srirajaskanthan R; Zen Y; Giwa M; Howard M; Ooft ML
    Histopathology; 2024 Jan; 84(2):255-265. PubMed ID: 37565289
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CT-guided percutaneous microwave ablation for pulmonary metastases from colorectal cancer: prognosis analyses based on the origin of the primary tumor.
    Huang Y; Wu K; Liu Y; Li D; Lai H; Peng T; Wan Y; Zhang B
    J Xray Sci Technol; 2023; 31(5):1001-1011. PubMed ID: 37424491
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cirrhosis in intrahepatic cholangiocarcinoma: prognostic importance and impact on survival.
    Thakral N; Gonzalez T; Nano O; Shin SH; Samuels S; Hussein A
    BMC Gastroenterol; 2023 May; 23(1):151. PubMed ID: 37179301
    [TBL] [Abstract] [Full Text] [Related]  

  • 7.
    Lu J; An SG; Ma JJ; Yang Y; Zhang L; Yu P; Tao H; Chen YF; Zhang HX
    Chin Med Sci J; 2022 Dec; 37(4):331-339. PubMed ID: 36647592
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Parathyroid carcinoma: Report of 10 patients and literature review.
    Miao XY; Wang XL; Lyu ZH; Ba JM; Pei Y; Dou JT; Gu WJ; Du J; Guo QH; Chen K; Mu YM
    Neuro Endocrinol Lett; 2022 Nov; 43(4):233-238. PubMed ID: 36528886
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The prognosis of elderly patients with hepatocellular carcinoma: A multi-center 19-year experience in Japan.
    Hatanaka T; Kakizaki S; Hiraoka A; Kariyama K; Tsuji K; Ishikawa T; Toyoda H; Yasuda S; Naganuma A; Tada T; Takaguchi K; Tsutsui A; Itobayashi E; Shimada N; Shibata H; Tanaka T; Nagano T; Imai M; Nakamura S; Nouso K; Kosaka H; Kaibori M; Kumada T;
    Cancer Med; 2023 Jan; 12(1):345-357. PubMed ID: 35608226
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Changes in serum lactate dehydrogenase levels as markers of pathological response and prognosis in colorectal liver metastases patients receiving neoadjuvant chemotherapy followed by resection.
    Chen J; Chen Q; Yao J; Jiang Y; Zhou J; Zhao H; Cai J
    Ann Palliat Med; 2021 Oct; 10(10):10276-10292. PubMed ID: 34551571
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus-related hepatocellular carcinoma.
    Lee JH; Kim BK; Park SY; Tak WY; Park JY; Kim DY; Ahn SH; Sinn DH; Kim SU
    Eur J Intern Med; 2021 Jul; 89():48-55. PubMed ID: 33810942
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Association of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung cancer Treated With Pembrolizumab Monotherapy.
    Sehgal K; Gill RR; Widick P; Bindal P; McDonald DC; Shea M; Rangachari D; Costa DB
    JAMA Netw Open; 2021 Feb; 4(2):e2037120. PubMed ID: 33570575
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Serum lactate level predicts 6-months mortality in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective study.
    Nie Y; Liu LX; Chen T; Zhang Y; Zhu X
    Epidemiol Infect; 2021 Jan; 149():e26. PubMed ID: 33397544
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Predictive effects of a combined indicator in patients with hepatocellular carcinoma after thermal ablation.
    Yang Q; Yu XL; Wang Y; Cheng ZG; Han ZY; Liu FY; Qian TG; Yu J; Liang P
    J Cancer Res Ther; 2020 Sep; 16(5):1038-1050. PubMed ID: 33004745
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Survival outcome of palliative primary tumor resection for colorectal cancer patients with synchronous liver and/or lung metastases: A retrospective cohort study in the SEER database by propensity score matching analysis.
    Chen X; Hu W; Huang C; Liang W; Zhang J; Wu D; Lv Z; Li Y; Luo Y; Liang Z; Wang M; Wang J; Yao X
    Int J Surg; 2020 Aug; 80():135-152. PubMed ID: 32634480
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors.
    Sonpavde G; Manitz J; Gao C; Tayama D; Kaiser C; Hennessy D; Makari D; Gupta A; Abdullah SE; Niegisch G; Rosenberg JE; Bajorin DF; Grivas P; Apolo AB; Dreicer R; Hahn NM; Galsky MD; Necchi A; Srinivas S; Powles T; Choueiri TK; Pond GR
    J Urol; 2020 Dec; 204(6):1173-1179. PubMed ID: 32552295
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification of FOS as a Candidate Risk Gene for liver cancer by Integrated Bioinformatic Analysis.
    Hu JW; Ding GY; Fu PY; Tang WG; Sun QM; Zhu XD; Shen YH; Zhou J; Fan J; Sun HC; Huang C
    Biomed Res Int; 2020; 2020():6784138. PubMed ID: 32280695
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic value of non-invasive fibrosis indices post-curative resection in hepatitis-B-associated hepatocellular carcinoma patients.
    Zhang TT; Ye SS; Liang J; Bai L
    Exp Biol Med (Maywood); 2020 Apr; 245(8):703-710. PubMed ID: 32223331
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
    Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
    BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome.
    Panzuto F; Merola E; Pavel ME; Rinke A; Kump P; Partelli S; Rinzivillo M; Rodriguez-Laval V; Pape UF; Lipp R; Gress T; Wiedenmann B; Falconi M; Delle Fave G
    Oncologist; 2017 Apr; 22(4):409-415. PubMed ID: 28232598
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.